News
Alzheimer's disease, Roche and New Drug
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...
8h
Breakthrough as two FDA-approved drugs are found to reverse Alzheimer’s — including restoring memory
Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.
Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...
A group of college students ended their coast-to-coast bike ride fighting Alzheimer’s disease in Virginia Beach on Sunday.
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
DPA International on MSN2d
EMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
Dear Abby gives advice to a reader whose friend has been rude since being diagnosed with early Alzheimer’s disease.
Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high ...
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results